Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 03 04:00PM ET
149.18
Dollar change
+2.19
Percentage change
1.49
%
IndexS&P 500 P/E27.40 EPS (ttm)5.44 Insider Own0.82% Shs Outstand174.60M Perf Week0.42%
Market Cap26.04B Forward P/E20.51 EPS next Y7.27 Insider Trans-6.76% Shs Float173.12M Perf Month-3.66%
Income969.00M PEG6.31 EPS next Q1.38 Inst Own87.16% Short Float2.31% Perf Quarter-4.19%
Sales5.34B P/S4.87 EPS this Y-26.75% Inst Trans-3.16% Short Ratio3.06 Perf Half Y23.49%
Book/sh27.54 P/B5.42 EPS next Y19.19% ROA11.07% Short Interest4.00M Perf Year4.64%
Cash/sh10.01 P/C14.90 EPS next 5Y4.34% ROE21.02% 52W Range118.57 - 172.72 Perf YTD-6.23%
Dividend Est.- P/FCF21.94 EPS past 5Y46.88% ROI15.57% 52W High-13.63% Beta1.03
Dividend TTM- Quick Ratio1.34 Sales past 5Y7.32% Gross Margin64.62% 52W Low25.82% ATR (14)3.10
Dividend Ex-Date- Current Ratio1.93 EPS Y/Y TTM-15.05% Oper. Margin23.62% RSI (14)47.70 Volatility1.75% 1.99%
Employees14900 Debt/Eq0.43 Sales Y/Y TTM-3.77% Profit Margin18.14% Recom2.09 Target Price162.44
Option/ShortYes / Yes LT Debt/Eq0.29 EPS Q/Q-32.34% Payout0.00% Rel Volume0.44 Prev Close146.99
Sales Surprise0.88% EPS Surprise2.78% Sales Q/Q-8.83% EarningsApr 30 AMC Avg Volume1.31M Price149.18
SMA20-1.19% SMA50-2.15% SMA2002.66% Trades Volume576,520 Change1.49%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Downgrade JP Morgan Overweight → Neutral $184 → $170
Sep-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $165
Sep-05-23Upgrade Goldman Neutral → Buy $146 → $164
Aug-18-23Downgrade Barclays Overweight → Equal Weight $204 → $144
Aug-14-23Downgrade BofA Securities Neutral → Underperform $163 → $148
Jun-30-23Initiated Citigroup Buy $200
Jan-11-23Downgrade Goldman Buy → Neutral $196 → $189
Jan-10-23Upgrade Barclays Equal Weight → Overweight $175 → $202
Nov-03-22Initiated Wells Fargo Overweight $200
Mar-11-22Upgrade Deutsche Bank Hold → Buy $176
Apr-30-24 11:00AM
Apr-29-24 11:00AM
08:00AM
Apr-24-24 11:00AM
Apr-18-24 11:00AM
11:47AM Loading…
Apr-04-24 11:47AM
Apr-03-24 11:00AM
Mar-29-24 06:47AM
Mar-28-24 08:05AM
03:50AM
03:21AM
03:16AM
Mar-27-24 05:44PM
04:23PM
04:19PM
04:16PM Loading…
04:16PM
Mar-25-24 11:00AM
Mar-21-24 11:30AM
Mar-20-24 12:41PM
11:00AM
Mar-19-24 01:00PM
11:00AM
Mar-13-24 11:00AM
Mar-12-24 12:16PM
Mar-11-24 11:00AM
Mar-06-24 11:00AM
10:37AM
Mar-05-24 11:00AM
Mar-01-24 11:01AM
Feb-29-24 12:56PM
11:00AM Loading…
11:00AM
Feb-28-24 11:00AM
01:30AM
Feb-27-24 11:00AM
08:51AM
Feb-26-24 03:17PM
11:00AM
Feb-25-24 11:00AM
Feb-23-24 12:21PM
08:00AM
Feb-22-24 11:00AM
Feb-21-24 01:00PM
12:12PM
11:00AM
09:50AM
09:43AM
08:41AM
01:13AM
Feb-20-24 06:00PM
05:15PM
04:31PM
04:18PM
04:05PM
Feb-19-24 12:10PM
11:37AM
Feb-16-24 11:00AM
09:14AM
Feb-15-24 11:00AM
Feb-14-24 09:15AM
Feb-13-24 11:00AM
10:00AM
09:12AM
Feb-12-24 11:00AM
Feb-08-24 07:27AM
Feb-01-24 11:00AM
Jan-31-24 11:00AM
08:39AM
Jan-30-24 11:00AM
11:00AM
09:45AM
08:00AM
Jan-29-24 01:00PM
11:00AM
Jan-25-24 11:00AM
Jan-24-24 11:00AM
09:00AM
Jan-22-24 07:00PM
Jan-18-24 06:30AM
Jan-16-24 11:00AM
Jan-10-24 04:05PM
Jan-09-24 12:55PM
11:00AM
Jan-03-24 11:30AM
Jan-02-24 11:00AM
Dec-29-23 07:01AM
Dec-20-23 11:30AM
Dec-19-23 09:04AM
Dec-18-23 07:25AM
Dec-16-23 01:22AM
Dec-15-23 11:00AM
10:06AM
Dec-14-23 06:39PM
Dec-13-23 11:00AM
06:52AM
Dec-12-23 11:00AM
Dec-10-23 05:05AM
Dec-05-23 11:00AM
Nov-30-23 04:10PM
04:05PM
11:18AM
Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization and secure operation of electronics systems to communications, networking and electronics industries. It operates through the following segments: Communications Solutions Group, and Electronic Industrial Solutions Group. The Communications Solutions Group segment serves customers spanning the worldwide commercial communications end market, which includes internet infrastructure, and the aerospace, defense and government end market. The Electronic Industrial Solutions Group segment offers test and measurement solutions across a broad set of electronic industrial end markets, focusing on high-growth applications in the automotive and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NARAYANAN KAILASHSVPMar 26 '24Sale152.884,300657,38429,156Mar 28 04:17 PM
Nersesian Ronald S.DirectorDec 27 '23Sale159.8229,6724,742,179296,619Dec 28 04:04 PM
Dougherty NeilEVP and CFODec 15 '23Sale159.3514,6862,340,214106,793Dec 18 05:36 PM
NARAYANAN KAILASHSVPDec 15 '23Sale159.161,006160,11733,456Dec 18 05:36 PM
Ee Huei SinSVPDec 14 '23Sale156.475,000782,32544,317Dec 15 05:45 PM
PAGE JOHNSVPDec 13 '23Sale150.006,155923,25036,767Dec 15 05:44 PM
Li Jeffrey KSVP and SecretaryDec 13 '23Sale150.004,748712,20028,174Dec 15 05:44 PM
Gooi Soon ChaiSVPDec 12 '23Sale148.0314,9002,205,592239,488Dec 13 04:22 PM
CULLEN JAMESDirectorDec 11 '23Sale146.474,869713,15420,730Dec 13 04:21 PM
Dhanasekaran SatishPresident and CEODec 06 '23Sale140.0011,1381,559,320105,139Dec 08 04:13 PM
Dhanasekaran SatishPresident and CEONov 27 '23Sale134.907,275981,398116,277Nov 29 04:16 PM
NARAYANAN KAILASHSVPJun 13 '23Sale165.0050082,50026,169Jun 14 04:15 PM
PAGE JOHNSVPJun 12 '23Sale163.8120,0003,276,21836,219Jun 14 04:15 PM
Gooi Soon ChaiSVPMay 30 '23Sale161.9529,1394,719,201227,874Jun 01 04:18 PM
HAMADA RICHARD PDirectorMay 23 '23Sale159.031,543245,38742,160May 25 04:09 PM
Stephens Kevin ADirectorMay 19 '23Buy157.4542066,1295,589May 22 04:45 PM
Last Close
May 03 04:00PM ET
76.54
Dollar change
+0.63
Percentage change
0.83
%
HOLX Hologic, Inc. daily Stock Chart
IndexS&P 500 P/E39.37 EPS (ttm)1.94 Insider Own1.28% Shs Outstand241.71M Perf Week0.74%
Market Cap17.97B Forward P/E17.26 EPS next Y4.43 Insider Trans-3.94% Shs Float231.72M Perf Month-0.96%
Income466.50M PEG5.32 EPS next Q1.02 Inst Own98.34% Short Float1.95% Perf Quarter5.66%
Sales3.96B P/S4.54 EPS this Y2.53% Inst Trans-9.74% Short Ratio2.66 Perf Half Y14.77%
Book/sh20.76 P/B3.69 EPS next Y9.19% ROA5.14% Short Interest4.52M Perf Year-8.98%
Cash/sh9.29 P/C8.24 EPS next 5Y7.40% ROE9.20% 52W Range64.02 - 86.74 Perf YTD7.12%
Dividend Est.- P/FCF18.93 EPS past 5Y- ROI6.33% 52W High-11.76% Beta1.02
Dividend TTM- Quick Ratio3.29 Sales past 5Y7.03% Gross Margin54.30% 52W Low19.56% ATR (14)1.51
Dividend Ex-Date- Current Ratio3.97 EPS Y/Y TTM-35.24% Oper. Margin21.72% RSI (14)51.68 Volatility2.51% 1.82%
Employees6990 Debt/Eq0.53 Sales Y/Y TTM-2.37% Profit Margin11.78% Recom2.11 Target Price85.86
Option/ShortYes / Yes LT Debt/Eq0.52 EPS Q/Q-18.23% Payout0.00% Rel Volume1.20 Prev Close75.91
Sales Surprise1.60% EPS Surprise5.34% Sales Q/Q-0.85% EarningsMay 02 AMC Avg Volume1.70M Price76.54
SMA20-0.01% SMA500.61% SMA2004.45% Trades Volume2,028,653 Change0.83%
Date Action Analyst Rating Change Price Target Change
Apr-03-24Upgrade Citigroup Neutral → Buy $80 → $95
Jul-14-23Upgrade Needham Hold → Buy $95
Dec-07-22Initiated RBC Capital Mkts Sector Perform $75
Oct-13-22Initiated Mizuho Buy $75
Jul-20-22Initiated UBS Neutral $73
Jul-20-22Downgrade BofA Securities Buy → Neutral $81 → $75
Jul-18-22Downgrade BTIG Research Buy → Neutral
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $75
Apr-04-22Downgrade Evercore ISI Outperform → In-line $80
Dec-15-21Downgrade Citigroup Buy → Neutral $85 → $78
Today 01:07AM
May-03-24 12:40PM
12:29PM
11:54AM
10:51AM
09:43AM Loading…
09:43AM
07:17AM
May-02-24 09:59PM
08:58PM
08:00PM
05:45PM
05:10PM
04:40PM
04:07PM
04:01PM
06:27AM Loading…
Apr-30-24 06:27AM
Apr-29-24 05:58PM
04:05PM
11:44AM
09:16AM
Apr-25-24 10:01AM
Apr-22-24 05:45PM
Apr-21-24 08:30AM
Apr-19-24 11:30AM
09:00AM
Apr-17-24 11:01AM
Apr-15-24 05:45PM
Apr-12-24 10:45AM
Apr-11-24 02:07PM
09:15AM
05:45PM Loading…
Apr-08-24 05:45PM
09:00AM
Apr-03-24 12:10PM
09:54AM
Apr-02-24 05:45PM
08:08AM
Mar-28-24 07:24AM
Mar-27-24 09:00AM
Mar-25-24 05:45PM
Mar-19-24 12:53PM
Mar-18-24 05:45PM
Mar-15-24 07:00PM
09:00AM
Mar-12-24 05:45PM
Mar-06-24 11:15AM
Mar-05-24 08:10AM
Mar-04-24 09:00AM
Feb-28-24 01:16AM
Feb-27-24 03:44PM
03:30PM
08:00AM
Feb-26-24 04:15PM
Feb-21-24 09:00AM
Feb-18-24 01:26PM
Feb-06-24 10:43AM
Feb-05-24 03:31PM
01:43PM
10:40AM
09:00AM
Feb-03-24 12:08AM
Feb-02-24 12:52PM
11:08AM
07:05AM
Feb-01-24 05:35PM
05:30PM
05:21PM
04:45PM
04:10PM
04:01PM
Jan-31-24 11:17AM
Jan-30-24 07:29PM
Jan-29-24 09:16AM
Jan-25-24 11:00AM
10:00AM
Jan-22-24 05:45PM
Jan-20-24 03:19PM
Jan-19-24 09:00AM
Jan-18-24 11:30AM
Jan-17-24 12:10PM
12:07PM
Jan-16-24 05:45PM
08:30AM
Jan-11-24 08:08AM
Jan-09-24 05:45PM
Jan-08-24 09:00AM
Jan-07-24 04:00PM
Jan-04-24 08:33AM
Jan-02-24 05:45PM
08:08AM
Dec-28-23 04:28AM
Dec-27-23 05:45PM
09:00AM
Dec-20-23 05:45PM
Dec-18-23 07:39AM
Dec-14-23 05:45PM
05:05PM
Dec-11-23 06:55AM
Dec-07-23 03:37AM
Dec-05-23 09:00AM
Dec-03-23 05:25AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARRETT SCOTT TDirectorMar 14 '24Option Exercise30.9316,441508,47165,052Mar 15 04:11 PM
GARRETT SCOTT TDirectorMar 14 '24Sale75.5016,4411,241,29648,611Mar 15 04:11 PM
CRAWFORD SALLYDirectorMar 08 '24Option Exercise26.749,039241,703141,966Mar 11 06:41 PM
CRAWFORD SALLYDirectorMar 08 '24Sale76.409,039690,607132,927Mar 11 06:41 PM
Dockendorff Charles JDirectorMar 08 '24Sale76.211,465111,6481,572Mar 11 06:45 PM
Oberton Karleen MarieChief Financial OfficerJan 29 '24Sale75.0014,9401,120,500103,916Jan 30 04:08 PM
Dockendorff Charles JDirectorJan 02 '24Option Exercise38.447,551290,26017,482Jan 04 04:09 PM
Dockendorff Charles JDirectorJan 02 '24Sale72.0016,0171,153,2241,465Jan 04 04:09 PM
GARRETT SCOTT TDirectorDec 11 '23Sale68.7110,000687,11647,039Dec 13 04:07 PM
MACMILLAN STEPHEN PChairman, President and CEONov 29 '23Option Exercise26.2147,7111,250,5051,286,799Dec 01 04:04 PM
MACMILLAN STEPHEN PChairman, President and CEONov 29 '23Sale70.4147,7113,359,1881,239,088Dec 01 04:04 PM
Mitchell Essex DDiv. President, GYN SurgicalNov 21 '23Sale71.857,500538,89012,827Nov 24 04:02 PM
GARRETT SCOTT TDirectorJun 15 '23Sale79.7210,000797,24057,039Jun 20 05:03 PM
Mitchell Essex DDiv. President, GYN SurgicalMay 05 '23Sale83.732,390200,1157,212May 09 04:18 PM
Last Close
May 03 04:00PM ET
94.40
Dollar change
+1.07
Percentage change
1.15
%
HAE Haemonetics Corp. daily Stock Chart
IndexRUT P/E38.30 EPS (ttm)2.46 Insider Own0.98% Shs Outstand50.45M Perf Week3.75%
Market Cap4.79B Forward P/E21.44 EPS next Y4.40 Insider Trans0.00% Shs Float50.29M Perf Month11.20%
Income126.57M PEG3.19 EPS next Q0.89 Inst Own100.98% Short Float4.45% Perf Quarter23.69%
Sales1.27B P/S3.77 EPS this Y30.66% Inst Trans-0.61% Short Ratio4.59 Perf Half Y9.27%
Book/sh18.57 P/B5.08 EPS next Y11.21% ROA6.21% Short Interest2.24M Perf Year15.42%
Cash/sh3.82 P/C24.72 EPS next 5Y12.00% ROE14.72% 52W Range70.74 - 95.26 Perf YTD10.40%
Dividend Est.- P/FCF37.57 EPS past 5Y21.43% ROI7.03% 52W High-0.90% Beta0.40
Dividend TTM- Quick Ratio1.76 Sales past 5Y5.50% Gross Margin51.78% 52W Low33.45% ATR (14)2.14
Dividend Ex-Date- Current Ratio2.92 EPS Y/Y TTM32.86% Oper. Margin15.76% RSI (14)76.15 Volatility1.99% 2.37%
Employees3034 Debt/Eq0.92 Sales Y/Y TTM12.48% Profit Margin9.97% Recom1.71 Target Price105.83
Option/ShortYes / Yes LT Debt/Eq0.91 EPS Q/Q-5.58% Payout0.00% Rel Volume0.76 Prev Close93.33
Sales Surprise4.80% EPS Surprise10.46% Sales Q/Q10.14% EarningsMay 09 BMO Avg Volume487.44K Price94.40
SMA208.75% SMA5015.51% SMA20011.11% Trades Volume368,663 Change1.15%
Date Action Analyst Rating Change Price Target Change
Oct-13-22Initiated Mizuho Buy $90
Jan-27-22Downgrade Needham Buy → Hold
Dec-15-21Downgrade Citigroup Buy → Neutral $75 → $59
Aug-17-21Resumed Raymond James Outperform $75
Jun-17-21Initiated Citigroup Buy $75
May-14-21Upgrade CJS Securities Market Perform → Market Outperform
Apr-20-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21Upgrade Barrington Research Mkt Perform → Outperform $140
Jan-21-21Downgrade Barrington Research Outperform → Mkt Perform
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
06:30AM Loading…
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
01:26PM Loading…
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
09:30AM
07:10AM
06:33AM
06:10AM
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
04:05PM Loading…
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
07:34AM
07:00AM
06:18AM
06:00AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
09:40AM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
11:05AM
Oct-17-23 11:17AM
08:33AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
08:14AM
Oct-11-23 12:00PM
11:13AM
08:23AM
Oct-10-23 06:00AM
06:00AM
Oct-09-23 08:35AM
Oct-06-23 07:48AM
Oct-05-23 04:05PM
11:16AM
09:51AM
08:32AM
08:25AM
Oct-04-23 09:50AM
09:40AM
08:47AM
Oct-03-23 11:11AM
08:56AM
Sep-29-23 09:45AM
08:49AM
08:32AM
Sep-28-23 10:37AM
09:06AM
Sep-27-23 09:12AM
07:47AM
Sep-26-23 11:10AM
11:06AM
08:02AM
Sep-25-23 11:40AM
09:45AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strong Stewart WPresident, Global HospitalSep 12 '23Sale90.6522820,66816,221Sep 13 04:19 PM
Lingamneni AnilaEVP, Chief Technology OfficerSep 11 '23Sale90.002,305207,45014,495Sep 13 04:20 PM
Dockendorff Charles JDirectorSep 05 '23Sale87.6810,215895,6512,226Sep 07 04:23 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Option Exercise57.104,928281,39023,391Jul 20 04:17 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Sale90.004,928443,52018,463Jul 20 04:17 PM
Simon, ChristopherPresident & CEOJun 29 '23Option Exercise28.61196,7465,629,887414,113Jun 30 04:17 PM
Strong Stewart WPresident, Global HospitalJun 07 '23Option Exercise56.936,893392,41924,040Jun 09 04:16 PM
Strong Stewart WPresident, Global HospitalJun 07 '23Sale88.042,538223,44616,449Jun 09 04:16 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 30 '23Sale83.332,304191,99216,800Jun 01 04:19 PM
Last Close
May 03 04:00PM ET
72.85
Dollar change
+0.82
Percentage change
1.14
%
BSX Boston Scientific Corp. daily Stock Chart
IndexS&P 500 P/E60.87 EPS (ttm)1.20 Insider Own0.45% Shs Outstand1.47B Perf Week-0.44%
Market Cap107.08B Forward P/E27.63 EPS next Y2.64 Insider Trans-5.73% Shs Float1.46B Perf Month7.53%
Income1.76B PEG4.91 EPS next Q0.58 Inst Own93.85% Short Float0.90% Perf Quarter13.17%
Sales14.71B P/S7.28 EPS this Y13.39% Inst Trans0.92% Short Ratio2.06 Perf Half Y41.02%
Book/sh13.56 P/B5.37 EPS next Y13.44% ROA5.09% Short Interest13.16M Perf Year38.26%
Cash/sh1.65 P/C44.21 EPS next 5Y12.40% ROE9.38% 52W Range48.35 - 74.39 Perf YTD26.02%
Dividend Est.- P/FCF63.06 EPS past 5Y-2.05% ROI5.91% 52W High-2.07% Beta0.81
Dividend TTM- Quick Ratio1.14 Sales past 5Y8.10% Gross Margin62.14% 52W Low50.67% ATR (14)1.35
Dividend Ex-Date- Current Ratio1.66 EPS Y/Y TTM104.30% Oper. Margin15.71% RSI (14)68.17 Volatility1.99% 1.69%
Employees48000 Debt/Eq0.55 Sales Y/Y TTM12.74% Profit Margin12.00% Recom1.41 Target Price81.70
Option/ShortYes / Yes LT Debt/Eq0.50 EPS Q/Q61.01% Payout0.00% Rel Volume1.13 Prev Close72.03
Sales Surprise4.67% EPS Surprise9.03% Sales Q/Q13.78% EarningsApr 24 BMO Avg Volume6.40M Price72.85
SMA204.47% SMA506.71% SMA20024.80% Trades Volume7,210,422 Change1.14%
Date Action Analyst Rating Change Price Target Change
Feb-01-24Upgrade Mizuho Neutral → Buy $65 → $80
Jul-19-23Initiated Robert W. Baird Outperform $59
Jun-30-23Initiated CL King Buy $64
May-30-23Resumed Morgan Stanley Overweight $58
Mar-29-23Initiated UBS Buy $57
Dec-22-22Initiated Mizuho Neutral $52
Dec-20-22Resumed Citigroup Buy $54
Oct-18-22Initiated Barclays Overweight $49
Oct-12-22Initiated Jefferies Buy $50
Jul-06-22Initiated Wolfe Research Outperform $43
May-03-24 01:06AM
May-02-24 04:53PM
07:05AM
May-01-24 08:00AM
Apr-30-24 02:29PM
04:22PM Loading…
Apr-29-24 04:22PM
09:40AM
Apr-26-24 11:32AM
09:50AM
08:20AM
Apr-25-24 11:34AM
10:53AM
10:25AM
10:21AM
09:45AM
08:35AM Loading…
08:35AM
08:19AM
07:53AM
03:01AM
Apr-24-24 11:21PM
04:19PM
02:42PM
01:38PM
01:11PM
12:40PM
12:04PM
11:54AM
11:33AM
11:16AM
10:00AM
07:51AM Loading…
07:51AM
07:40AM
07:20AM
07:11AM
06:53AM
06:39AM
06:35AM
06:30AM
Apr-23-24 06:14AM
Apr-19-24 09:15AM
Apr-18-24 12:02PM
05:57AM
Apr-17-24 03:37PM
02:38PM
Apr-16-24 10:44AM
04:13AM
Apr-13-24 12:18PM
Apr-10-24 09:30AM
Apr-08-24 12:00AM
Apr-04-24 05:16PM
07:45AM
07:31AM
06:03AM
Apr-01-24 08:00AM
Mar-28-24 08:03AM
Mar-25-24 09:30PM
Mar-24-24 09:35AM
Mar-22-24 04:01PM
01:41AM
Mar-18-24 01:22PM
09:28AM
Mar-15-24 06:00AM
Mar-13-24 02:17PM
Mar-07-24 05:00AM
Mar-06-24 11:48AM
Mar-04-24 11:27AM
Mar-01-24 11:30AM
09:50AM
07:21AM
07:07AM
06:55AM
06:23AM
Feb-29-24 06:00AM
Feb-28-24 05:52PM
06:08AM
Feb-27-24 04:15PM
09:15AM
02:03AM
Feb-22-24 09:27PM
Feb-21-24 11:54AM
09:04AM
12:08AM
Feb-20-24 11:25AM
Feb-18-24 01:26PM
Feb-17-24 01:29PM
Feb-16-24 12:56PM
Feb-14-24 08:15AM
Feb-08-24 10:34AM
Feb-07-24 09:28AM
08:45AM
Feb-06-24 10:41AM
Feb-05-24 08:00AM
Feb-02-24 08:15AM
08:09AM
Feb-01-24 09:14AM
01:55AM
Jan-31-24 07:40PM
04:07PM
11:55AM
11:02AM
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sorenson John BradleyEVP, Global OperationsMay 01 '24Option Exercise17.2617,587303,55268,225May 02 04:46 PM
Carruthers WendyEVP, Human ResourcesMay 01 '24Option Exercise19.314,26382,30655,331May 02 04:42 PM
Sorenson John BradleyEVP, Global OperationsMay 01 '24Sale71.5017,5871,257,48850,638May 02 04:46 PM
Carruthers WendyEVP, Human ResourcesMay 01 '24Sale71.476,983499,07548,348May 02 04:42 PM
LUDWIG EDWARD JDirectorApr 26 '24Option Exercise17.379,818170,53951,192Apr 29 04:12 PM
LUDWIG EDWARD JDirectorApr 26 '24Sale73.299,818719,56241,374Apr 29 04:12 PM
Sorenson John BradleyEVP, Global OperationsApr 01 '24Option Exercise16.3116,351266,68566,989Apr 02 06:57 PM
Carruthers WendyEVP, Human ResourcesApr 01 '24Option Exercise19.314,26382,30658,051Apr 02 06:57 PM
Sorenson John BradleyEVP, Global OperationsApr 01 '24Sale69.3016,3511,133,06950,638Apr 02 06:57 PM
Carruthers WendyEVP, Human ResourcesApr 01 '24Sale68.426,983477,77751,068Apr 02 06:57 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventMar 18 '24Sale66.4514,506963,93058,098Mar 19 04:41 PM
Carruthers WendyEVP, Human ResourcesMar 01 '24Option Exercise19.314,26382,30660,771Mar 04 06:50 PM
Carruthers WendyEVP, Human ResourcesMar 01 '24Sale66.356,983463,32253,788Mar 04 06:50 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 26 '24Option Exercise21.404,18589,54238,272Feb 27 04:19 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 26 '24Sale67.079,335626,09828,937Feb 27 04:19 PM
Carruthers WendyEVP, Human ResourcesFeb 23 '24Option Exercise19.314,26382,30663,491Feb 26 04:13 PM
Carruthers WendyEVP, Human ResourcesFeb 23 '24Sale66.896,983467,09356,508Feb 26 04:13 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 21 '24Sale66.354,960329,09672,604Feb 22 04:19 PM
Brennan Daniel J.EVP and CFOFeb 20 '24Option Exercise13.0813,662178,699285,204Feb 20 09:03 PM
Brennan Daniel J.EVP and CFOFeb 20 '24Sale65.8613,662899,779271,542Feb 20 09:03 PM
Sorenson John BradleyEVP, Global OperationsFeb 18 '24Option Exercise0.001,186051,179Feb 20 09:05 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 18 '24Option Exercise0.002,002031,204Feb 20 09:05 PM
Brown Vance RSVP, GC and Corp. SecretaryFeb 18 '24Option Exercise0.00741032,544Feb 20 09:03 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 18 '24Option Exercise0.003,7060194,696Feb 20 09:03 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 18 '24Option Exercise0.002,372035,139Feb 20 09:03 PM
Brennan Daniel J.EVP and CFOFeb 18 '24Option Exercise0.003,7060273,186Feb 20 09:03 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 18 '24Option Exercise0.002,817078,849Feb 20 09:04 PM
Monson JonathanSVP, Global Controller and CAOFeb 18 '24Option Exercise0.00638038,240Feb 20 09:04 PM
Mahoney Michael FChairman, President & CEOFeb 18 '24Option Exercise0.0016,30701,681,111Feb 20 09:03 PM
Carruthers WendyEVP, Human ResourcesFeb 18 '24Option Exercise0.001,853063,100Feb 20 09:03 PM
Carruthers WendyEVP, Human ResourcesFeb 17 '24Option Exercise0.002,250062,245Feb 20 09:03 PM
Mahoney Michael FChairman, President & CEOFeb 17 '24Option Exercise0.0018,33301,672,935Feb 20 09:03 PM
Monson JonathanSVP, Global Controller and CAOFeb 17 '24Option Exercise0.001,000038,006Feb 20 09:04 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 17 '24Option Exercise0.003,333077,552Feb 20 09:04 PM
Brennan Daniel J.EVP and CFOFeb 17 '24Option Exercise0.004,5830271,513Feb 20 09:03 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 17 '24Option Exercise0.002,833034,024Feb 20 09:03 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 17 '24Option Exercise0.004,1670193,047Feb 20 09:03 PM
Brown Vance RSVP, GC and Corp. SecretaryFeb 17 '24Option Exercise0.001,000032,097Feb 20 09:03 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 17 '24Option Exercise0.002,500030,650Feb 20 09:05 PM
Sorenson John BradleyEVP, Global OperationsFeb 17 '24Option Exercise0.001,500050,678Feb 20 09:05 PM
Sorenson John BradleyEVP, Global OperationsFeb 16 '24Option Exercise0.001,273049,759Feb 20 09:05 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 16 '24Option Exercise0.002,263029,461Feb 20 09:05 PM
Brown Vance RSVP, GC and Corp. SecretaryFeb 16 '24Option Exercise0.001,838031,637Feb 20 09:03 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 16 '24Option Exercise0.003,9600190,686Feb 20 09:03 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 16 '24Option Exercise0.002,546032,321Feb 20 09:03 PM
Brennan Daniel J.EVP and CFOFeb 16 '24Option Exercise0.004,2430268,812Feb 20 09:03 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 16 '24Option Exercise0.002,970075,574Feb 20 09:04 PM
Monson JonathanSVP, Global Controller and CAOFeb 16 '24Option Exercise0.00990037,433Feb 20 09:04 PM
Mahoney Michael FChairman, President & CEOFeb 16 '24Option Exercise0.0016,26501,661,816Feb 20 09:03 PM
Carruthers WendyEVP, Human ResourcesFeb 16 '24Option Exercise0.002,051060,905Feb 20 09:03 PM
Monson JonathanSVP, Global Controller and CAOFeb 14 '24Option Exercise0.001,057036,931Feb 16 04:22 PM
Sorenson John BradleyEVP, Global OperationsFeb 14 '24Option Exercise0.002,115049,451Feb 16 04:23 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 14 '24Option Exercise0.002,379028,576Feb 16 04:23 PM
Brennan Daniel J.EVP and CFOFeb 14 '24Option Exercise0.004,3620266,504Feb 16 04:21 PM
Brown Vance RSVP, GC and Corp. SecretaryFeb 14 '24Option Exercise0.001,850030,428Feb 16 04:21 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 14 '24Option Exercise0.003,172031,183Feb 16 04:21 PM
Carruthers WendyEVP, Human ResourcesFeb 14 '24Option Exercise0.002,115059,793Feb 16 04:21 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 14 '24Option Exercise0.004,3620188,716Feb 16 04:21 PM
Mahoney Michael FChairman, President & CEOFeb 14 '24Option Exercise0.0016,52301,652,879Feb 16 04:22 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 14 '24Option Exercise0.002,776073,870Feb 16 04:22 PM
LUDWIG EDWARD JDirectorFeb 13 '24Option Exercise17.377,000121,59048,374Feb 14 04:23 PM
LUDWIG EDWARD JDirectorFeb 13 '24Sale65.037,000455,22341,374Feb 14 04:23 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyJan 12 '24Sale60.0011,660699,600173,472Jan 16 04:39 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 09 '24Option Exercise16.3115,172247,45571,760Jan 10 05:44 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 09 '24Sale59.2515,172898,94156,588Jan 10 05:44 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 04 '24Option Exercise16.3115,000244,65071,588Jan 05 04:53 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 04 '24Sale58.4015,000876,00256,588Jan 05 04:53 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 03 '24Sale57.8211,931689,86256,588Jan 04 04:15 PM
Mahoney Michael FChairman, President & CEOJan 01 '24Option Exercise0.0095,91901,594,841Jan 02 08:31 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 01 '24Option Exercise0.0017,439074,027Jan 02 08:31 PM
Sorenson John BradleyEVP, Global OperationsJan 01 '24Option Exercise0.007,848044,537Jan 02 08:31 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrJan 01 '24Option Exercise0.0013,080025,349Jan 02 08:31 PM
Brennan Daniel J.EVP and CFOJan 01 '24Option Exercise0.0023,9790249,937Jan 02 08:30 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACJan 01 '24Option Exercise0.0014,823021,800Jan 02 08:30 PM
Carruthers WendyEVP, Human ResourcesJan 01 '24Option Exercise0.0011,772053,041Jan 02 08:30 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyJan 01 '24Option Exercise0.0021,7990196,040Jan 02 08:30 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyDec 29 '23Option Exercise16.3158,189949,063256,181Jan 02 08:30 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyDec 29 '23Sale57.5081,9404,711,550174,241Jan 02 08:30 PM
Carruthers WendyEVP, Human ResourcesDec 15 '23Option Exercise14.826,40994,97352,941Dec 18 04:11 PM
Carruthers WendyEVP, Human ResourcesDec 15 '23Sale55.6111,672649,07541,269Dec 18 04:11 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventDec 06 '23Sale55.0335319,42656,588Dec 07 04:10 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventDec 03 '23Option Exercise0.00649057,237Dec 04 05:42 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACNov 20 '23Option Exercise17.263,85966,60615,255Nov 21 04:15 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACNov 20 '23Sale54.068,278447,5096,977Nov 21 04:15 PM
Carruthers WendyEVP, Human ResourcesNov 15 '23Option Exercise14.826,40894,95458,203Nov 16 04:16 PM
Carruthers WendyEVP, Human ResourcesNov 15 '23Sale54.1711,671632,26946,532Nov 16 04:16 PM
Mahoney Michael FChairman, President & CEONov 06 '23Option Exercise14.67113,3561,662,5271,612,278Nov 07 04:11 PM
Mahoney Michael FChairman, President & CEONov 06 '23Sale52.51113,3565,951,9831,498,922Nov 07 04:11 PM
Carruthers WendyEVP, Human ResourcesOct 16 '23Option Exercise14.826,40894,95463,466Oct 17 04:12 PM
Carruthers WendyEVP, Human ResourcesOct 16 '23Sale49.7911,671581,06351,795Oct 17 04:12 PM
Mahoney Michael FChairman, President & CEOOct 09 '23Option Exercise14.67113,3551,662,5141,612,277Oct 10 06:11 PM
Mahoney Michael FChairman, President & CEOOct 09 '23Sale52.09113,3555,904,4811,498,922Oct 10 06:11 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologySep 20 '23Sale55.0015,867872,685197,992Sep 21 04:09 PM
Carruthers WendyEVP, Human ResourcesSep 15 '23Option Exercise14.826,40894,95468,729Sep 15 06:34 PM
Carruthers WendyEVP, Human ResourcesSep 15 '23Sale53.9511,671629,69457,058Sep 15 06:34 PM
Mahoney Michael FChairman, President & CEOSep 12 '23Option Exercise14.67113,3551,662,5141,612,277Sep 12 05:37 PM
Mahoney Michael FChairman, President & CEOSep 12 '23Sale53.91113,3556,110,4471,498,922Sep 12 05:37 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventAug 29 '23Sale54.504,657253,81160,588Aug 30 04:10 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventAug 28 '23Sale53.1413,971742,41965,245Aug 30 04:10 PM
Brown Vance RSVP, GC and Corp. SecretaryAug 25 '23Sale50.5215,750795,75628,578Aug 28 04:18 PM